Scott Gottlieb

Guests Steve Witkoff, Trump's former top negotiator, discusses the complexities of Middle East peace talks and the delicate balance in Israel-Hamas negotiations. Former FDA commissioner Scott Gottlieb highlights the urgent public health crises, focusing on alarming measles outbreaks and the need to combat vaccine misinformation. They dive into the repercussions of workforce cuts in health agencies and how these changes could affect American health oversight moving forward. Expect a thought-provoking discussion on governance, health, and international diplomacy.

This podcast features Scott Gottlieb, the former FDA Commissioner and current board member for Pfizer, who discusses the vital effects of funding cuts on health research and the innovation pipeline. Additionally, investor Steve Eisman shares his outlook on market risks tied to the Israel-Iran conflict and the potential for a trade war, offering his unique insights on navigating these turbulent times. The discussion also hints at the emerging drama between OpenAI and Microsoft and the public market ambitions of crypto billionaire Justin Sun.

Scott Gottlieb, former FDA commissioner and healthcare expert, and Patrick Boyle, financial commentator and YouTuber, dive into pressing topics. They explore the political implications of vaccine announcements and transparency issues with big pharma, specifically Pfizer. The conversation shifts to the fintech landscape, discussing the risks of debanking practices and regulatory scrutiny. Gottlieb and Boyle also touch on the geopolitical landscape, with insights into the Ukraine conflict and its broader implications for international relations.

Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, shares his insights on vaccine regulation, emphasizing the challenges faced during the Trump administration. He highlights the importance of robust FDA processes and expresses concerns over public health implications. The discussion also touches on highlights from the DealBook Summit, including takes from Israeli Prime Minister Netanyahu and Palantir's Alex Karp, who critiques modern politics, providing a rich tapestry of perspectives on pressing issues.

Dan Niles, a tech investor and founder of Niles Investment Management, discusses the surge in technology stocks and the implications of AI on investment strategies. He highlights Google's milestone of a $3 trillion market cap and the bullish sentiment surrounding Apple’s new iPhones. Scott Gottlieb, former FDA Commissioner, examines vaccine-related news and upcoming CDC policies, emphasizing public health trends and regulatory challenges. Together, they explore the intersection of tech and healthcare, shedding light on current market dynamics and future prospects.

Scott Gottlieb, former FDA commissioner and board member at Pfizer and Illumina, discusses the stark divide between Nvidia and Broadcom in the semiconductor market. He delves into the implications of a weaker jobs report, which raises the prospect of a September rate cut by the Fed, signaling a potentially weakening economy. Gottlieb also examines how this volatility in tech stocks could influence broader market dynamics, alongside concerns about sustainability in the AI sector amidst these economic challenges.

Scott Gottlieb, former head of the FDA and author of 'Uncontrolled Spread,' dives into the lessons learned from the COVID-19 pandemic. He discusses the critical role technology, particularly mRNA vaccine development, played in pandemic response and highlights failures in regulatory translation of science to policy. Joining him are Marc Andreessen, a prominent venture capitalist, and Vineeta Agarwala, a bio expert. They explore the need for improved genomic surveillance, private sector involvement in health infrastructure, and the ethical dilemmas of challenge trials for future preparedness.

Gerry Cardinale, founder of RedBird Capital Partners and key investor in Paramount's bid for Warner Bros., discusses the details of an amended $30 billion offer amidst competitive pressure from Netflix. He highlights the importance of direct shareholder engagement and addresses regulatory concerns. Meanwhile, Dr. Scott Gottlieb, former FDA Commissioner, raises alarms about the implications of adopting a Danish-style vaccine schedule in the U.S., emphasizing potential risks to children's health and the ongoing debate on drug pricing reforms.

Vivek Ramaswamy, an Ohio gubernatorial candidate and entrepreneur, joins former FDA Commissioner Scott Gottlieb for a riveting discussion on the alarming decline in American support for capitalism. They dissect the rise of socialist sentiments and tackle the national affordability crisis. Gottlieb also sheds light on vaccine access issues, influenced by current political dynamics. Together, they explore the challenges of housing affordability and the pressing need for innovative solutions to elevate the American economic landscape.

Senator Elizabeth Warren, a key Democratic voice in banking, challenges Fed Chair Jay Powell on interest rates and inflation, discussing economic policies that affect everyday Americans. Meanwhile, Dr. Scott Gottlieb, former FDA Commissioner, reveals insights on the CDC's shifting vaccine strategies amidst rising anti-vaccine sentiment. The duo navigates the intersection of economic decisions and public health initiatives, highlighting the importance of balanced policies and the ongoing debate around vaccine safety and accessibility.